Apple Watch Blood Oxygen Workaround Sparks Lawsuit
Apple faces a new lawsuit over its blood oxygen monitoring workaround on Apple Watch, raising questions about patents and user access.
Matilda
Apple Watch Blood Oxygen Workaround Sparks Lawsuit Triggers New Masimo Lawsuit Apple Watch blood oxygen monitoring has once again sparked legal tensions, as medical technology company Masimo has filed a fresh lawsuit challenging Apple’s workaround. After the U.S. Customs and Border Protection (CBP) recently allowed Apple to reintroduce the feature through a software-based method, Masimo argues the decision violates existing patent rulings. Many Apple Watch users have been curious about why this feature disappeared and returned, and the ongoing legal battle sheds light on the complicated relationship between innovation, patents, and health technology. Image : Google Apple Watch Blood Oxygen Monitoring Dispute
The heart of the conflict lies in Apple’s use of pulse oximetry technology, which Masimo claims infringes on its patents. In December 2023, the International Trade Commission (ITC) ruled against Apple, resulting in a temporary import ban on newer watch models. Apple later removed the blood oxygen feature in compliance but has now rei…